Merck Support For ClinicalTrials.Gov Expansion Does Not Mean Company Will Add Listings
This article was originally published in The Pink Sheet Daily
Executive Summary
Merck says it prefers to continue to fly below the radar screen with respect to ClinicalTrials.gov unless the law is changed. Merck's response to AMA's clinical trials registry proposal receives national media attention, but the company is an unlikely champion for government-sponsored public trial databases.